Nanostim, Inc.

medical devices

About

Nanostim, Inc. was a medical device company focused on developing miniaturized, leadless pacemakers. Its main product, the Nanostim™ leadless pacemaker, innovatively eliminated the need for traditional leads and surgical pockets. This device was designed for implantation directly into the heart through a minimally invasive procedure using a steerable catheter, which reduced surgical risks and complications. The Nanostim leadless pacemaker received CE Mark approval for marketing in select European countries and obtained conditional approval from the U.S. Food and Drug Administration to begin pivotal clinical trials. In 2013, Nanostim was acquired by St. Jude Medical for $123.5 million, integrating its leadless pacemaker technology into St. Jude Medical’s product portfolio. This acquisition marked a significant advancement in cardiac pacing technology.

Technologies

Akamai DNS Route 53 Marketo Amazon AWS DoubleClick AppNexus Google Tag Manager Facebook Widget Facebook Custom Audiences Google AdSense Rubicon Project TripleLift New Relic Facebook Login (Connect) DoubleClick Floodlight LiveRamp Google Analytics Mobile Friendly Google AdWords Conversion ON24

Keywords

medical device medical device cardiac rhythm management pacemakers cardiac rhythm management pacemakers mobile e-commerce productivity software consumer internet internet information technology medical equipment manufacturing hospital & health care information technology & services consumers computer software medical devices

Location

776 Palomar Ave, Sunnyvale, California, United States, 94085

Related Companies

Companies in the same industry